A cytochrome P450 CYP87A4 imparts sterol side-chain cleavage in digoxin biosynthesis

Abstract Digoxin extracted from the foxglove plant is a widely prescribed natural product for treating heart failure. It is listed as an essential medicine by the World Health Organization. However, how the foxglove plant synthesizes digoxin is mostly unknown, especially the cytochrome P450 sterol s...

Full description

Bibliographic Details
Main Authors: Emily Carroll, Baradwaj Ravi Gopal, Indu Raghavan, Minakshi Mukherjee, Zhen Q. Wang
Format: Article
Language:English
Published: Nature Portfolio 2023-07-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-023-39719-4
_version_ 1797784555116036096
author Emily Carroll
Baradwaj Ravi Gopal
Indu Raghavan
Minakshi Mukherjee
Zhen Q. Wang
author_facet Emily Carroll
Baradwaj Ravi Gopal
Indu Raghavan
Minakshi Mukherjee
Zhen Q. Wang
author_sort Emily Carroll
collection DOAJ
description Abstract Digoxin extracted from the foxglove plant is a widely prescribed natural product for treating heart failure. It is listed as an essential medicine by the World Health Organization. However, how the foxglove plant synthesizes digoxin is mostly unknown, especially the cytochrome P450 sterol side chain cleaving enzyme (P450scc), which catalyzes the first and rate-limiting step. Here we identify the long-speculated foxglove P450scc through differential transcriptomic analysis. This enzyme converts cholesterol and campesterol to pregnenolone, suggesting that digoxin biosynthesis starts from both sterols, unlike previously reported. Phylogenetic analysis indicates that this enzyme arises from a duplicated cytochrome P450 CYP87A gene and is distinct from the well-characterized mammalian P450scc. Protein structural analysis reveals two amino acids in the active site critical for the foxglove P450scc’s sterol cleavage ability. Identifying the foxglove P450scc is a crucial step toward completely elucidating digoxin biosynthesis and expanding the therapeutic applications of digoxin analogs in future work.
first_indexed 2024-03-13T00:41:34Z
format Article
id doaj.art-55aa15c6be9c488f94797f5dd2c20c9b
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-03-13T00:41:34Z
publishDate 2023-07-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-55aa15c6be9c488f94797f5dd2c20c9b2023-07-09T11:17:39ZengNature PortfolioNature Communications2041-17232023-07-0114111110.1038/s41467-023-39719-4A cytochrome P450 CYP87A4 imparts sterol side-chain cleavage in digoxin biosynthesisEmily Carroll0Baradwaj Ravi Gopal1Indu Raghavan2Minakshi Mukherjee3Zhen Q. Wang4Department of Biological Sciences, University at Buffalo, the State University of New YorkDepartment of Biological Sciences, University at Buffalo, the State University of New YorkDepartment of Biological Sciences, University at Buffalo, the State University of New YorkDepartment of Biological Sciences, University at Buffalo, the State University of New YorkDepartment of Biological Sciences, University at Buffalo, the State University of New YorkAbstract Digoxin extracted from the foxglove plant is a widely prescribed natural product for treating heart failure. It is listed as an essential medicine by the World Health Organization. However, how the foxglove plant synthesizes digoxin is mostly unknown, especially the cytochrome P450 sterol side chain cleaving enzyme (P450scc), which catalyzes the first and rate-limiting step. Here we identify the long-speculated foxglove P450scc through differential transcriptomic analysis. This enzyme converts cholesterol and campesterol to pregnenolone, suggesting that digoxin biosynthesis starts from both sterols, unlike previously reported. Phylogenetic analysis indicates that this enzyme arises from a duplicated cytochrome P450 CYP87A gene and is distinct from the well-characterized mammalian P450scc. Protein structural analysis reveals two amino acids in the active site critical for the foxglove P450scc’s sterol cleavage ability. Identifying the foxglove P450scc is a crucial step toward completely elucidating digoxin biosynthesis and expanding the therapeutic applications of digoxin analogs in future work.https://doi.org/10.1038/s41467-023-39719-4
spellingShingle Emily Carroll
Baradwaj Ravi Gopal
Indu Raghavan
Minakshi Mukherjee
Zhen Q. Wang
A cytochrome P450 CYP87A4 imparts sterol side-chain cleavage in digoxin biosynthesis
Nature Communications
title A cytochrome P450 CYP87A4 imparts sterol side-chain cleavage in digoxin biosynthesis
title_full A cytochrome P450 CYP87A4 imparts sterol side-chain cleavage in digoxin biosynthesis
title_fullStr A cytochrome P450 CYP87A4 imparts sterol side-chain cleavage in digoxin biosynthesis
title_full_unstemmed A cytochrome P450 CYP87A4 imparts sterol side-chain cleavage in digoxin biosynthesis
title_short A cytochrome P450 CYP87A4 imparts sterol side-chain cleavage in digoxin biosynthesis
title_sort cytochrome p450 cyp87a4 imparts sterol side chain cleavage in digoxin biosynthesis
url https://doi.org/10.1038/s41467-023-39719-4
work_keys_str_mv AT emilycarroll acytochromep450cyp87a4impartssterolsidechaincleavageindigoxinbiosynthesis
AT baradwajravigopal acytochromep450cyp87a4impartssterolsidechaincleavageindigoxinbiosynthesis
AT induraghavan acytochromep450cyp87a4impartssterolsidechaincleavageindigoxinbiosynthesis
AT minakshimukherjee acytochromep450cyp87a4impartssterolsidechaincleavageindigoxinbiosynthesis
AT zhenqwang acytochromep450cyp87a4impartssterolsidechaincleavageindigoxinbiosynthesis
AT emilycarroll cytochromep450cyp87a4impartssterolsidechaincleavageindigoxinbiosynthesis
AT baradwajravigopal cytochromep450cyp87a4impartssterolsidechaincleavageindigoxinbiosynthesis
AT induraghavan cytochromep450cyp87a4impartssterolsidechaincleavageindigoxinbiosynthesis
AT minakshimukherjee cytochromep450cyp87a4impartssterolsidechaincleavageindigoxinbiosynthesis
AT zhenqwang cytochromep450cyp87a4impartssterolsidechaincleavageindigoxinbiosynthesis